[1]陈 蓉,刘梦颖.小儿肺热咳喘口服液联合头孢克洛干混悬剂治疗小儿支气管肺炎的效果及对C反应蛋白水平的影响[J].医学信息,2025,38(07):129-132.[doi:10.3969/j.issn.1006-1959.2025.07.025]
　CHEN Rong,LIU Mengying.Effect of Xiao’er Feire Kechuan Oral Liquid Combined with Cefaclor for Oral Suspension on Bronchopneumonia in Children and its Effect on C-reactive Protein Level[J].Journal of Medical Information,2025,38(07):129-132.[doi:10.3969/j.issn.1006-1959.2025.07.025]
点击复制

小儿肺热咳喘口服液联合头孢克洛干混悬剂治疗小儿支气管肺炎的效果及对C反应蛋白水平的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
38卷
期数:
2025年07期
页码:
129-132
栏目:
论著
出版日期:
2025-04-01

文章信息/Info

Title:
Effect of Xiao’er Feire Kechuan Oral Liquid Combined with Cefaclor for Oral Suspension on Bronchopneumonia in Children and its Effect on C-reactive Protein Level
文章编号:
1006-1959（2025）07-0129-04
作者:
陈 蓉1; 刘梦颖2
1.宜春市袁州区妇幼保健院儿科，江西 宜春 336000；2.宜春市疾病预防控制中心检验科，江西 宜春 336000
Author(s):
CHEN Rong1;  LIU Mengying2
1.Department of Pediatrics, Yichun Yuanzhou District Maternal and Child Health Hospital, Yichun 336000, Jiangxi, China;2.Department of Clinical Laboratory, Yichun Center for Disease Control and Prevention, Yichun 336000, Jiangxi, China
关键词:
小儿肺热咳喘口服液; 头孢克洛干混悬剂; 小儿支气管肺炎; C反应蛋白
Keywords:
Xiao′er Feire Kechuan oral liquid;  Cefaclor for oral suspension;  Bronchopneumonia in children;  C-reactive protein
分类号:
R725.6
DOI:
10.3969/j.issn.1006-1959.2025.07.025
文献标志码:
A
摘要:
目的 探究小儿肺热咳喘口服液联合头孢克洛干混悬剂治疗小儿支气管肺炎的临床效果及对C反应蛋白水平的影响。方法 将2020年1月-2023年12月宜春市袁州区妇幼保健院确诊为支气管肺炎的60例患儿作为研究对象，并按照随机数字表法分为对照组和研究组，每组30例。对照组应用头孢克洛干混悬剂治疗，研究组在对照组治疗基础上联合应用小儿肺热咳喘口服液治疗。比较两组治疗效果、临床症状及体征消失时间（退热时间、咳嗽消失时间、肺部啰音消失时间、胸片恢复正常时间）、炎症因子水平[C-反应蛋白（CRP）]、不良反应（口腔炎、鼻液溢、恶心呕吐、胃炎）发生率。结果 与对照组治疗总有效率的73.33%比较，研究组治疗总有效率更高，达96.67%（P＜0.05）；与对照组比较，研究组退热时间、咳嗽消失时间、肺部啰音消失时间、胸片恢复正常时间更短，且治疗后CRP水平更低（P＜0.05）；与对照组不良反应发生率的23.33%比较，研究组不良反应发生率更低，仅为6.67%（P＜0.05）。结论 小儿肺热咳喘口服液联合头孢克洛干混悬剂治疗小儿支气管肺炎的临床效果确切，可改善患者炎症因子水平，加快患儿临床症状消失，且具有较高的用药安全性。
Abstract:
Objective To explore the clinical effect of Xiao′er Feire Kechuan oral liquid combined with cefaclor for oral suspension in the treatment of bronchopneumonia in children and its effect on C-reactive protein level. Methods A total of 60 children diagnosed with bronchopneumonia in Yichun Yuanzhou District Maternal and Child Health Hospital from January 2020 to December 2023 were selected as the research objects, and they were divided into control group and study group according to the random number table method, with 30 children in each group. The control group was treated with cefaclor for oral suspension, and the study group was treated with Xiao′er Feire Kechuan oral liquid on the basis of the control group. The therapeutic effect, disappearance time of clinical symptoms and signs (antipyretic time, cough disappearance time, lung rale disappearance time, chest X-ray recovery time), inflammatory factor level [C-reactive protein (CRP)] and incidence of adverse reactions (stomatitis, nasal discharge, nausea and vomiting, gastritis) were compared between the two groups. Results Compared with 73.33% of the total effective rate of the control group, the total effective rate of the study group was higher, reaching 96.67% (P<0.05). Compared with the control group, the antipyretic time, cough disappearance time, lung rale disappearance time and chest X-ray recovery time in the study group were shorter, and the CRP level was lower after treatment (P<0.05). Compared with 23.33% of the incidence of adverse reactions in the control group, the incidence of adverse reactions in the study group was lower, only 6.67% (P<0.05). Conclusion Xiao′er Feire Kechuan oral liquid combined with cefaclor for oral suspension has a definite clinical effect in the treatment of bronchopneumonia in children, which can improve their inflammatory factor level, accelerate the disappearance of clinical symptoms, and has high medication safety.

参考文献/References:

[1]杨娟,郭亚楠.小儿肺热咳喘口服液联合西药治疗儿童支气管肺炎的疗效及作用机制[J].中药材,2021,44(2):461-464.[2]周维维,李冬梅,任耀全,等.基于痰瘀同治探讨麻杏化瘀汤对痰热闭肺型支气管肺炎患儿血清淀粉样蛋白含量的影响[J].中华中医药学刊,2023,41(3):227-230.[3]李连家,孙玉军,马海凤,等.小儿肺热咳喘口服液联合美洛西林钠及阿奇霉素治疗小儿肺炎链球菌肺炎的临床疗效及其对免疫炎症因子的影响[J].世界中西医结合杂志,2021,16(6):1137-1140.[4]李娟.小儿肺热咳喘口服液联合阿奇霉素治疗儿童支原体肺炎的疗效观察[J].传染病信息,2019,32(2):151-153.[5]王艳,林占元,金婉怡.丹参联合小儿肺热咳喘口服液对重症肺炎患儿凝血指标及血小板参数的影响[J].血栓与止血学,2019,25(5):753-755.[6]韩金芬,柳晓艳,王会娟.阿奇霉素联合小儿肺热咳喘口服液治疗儿童支原体肺炎疗效观察[J].新乡医学院学报,2016,33(6):483-484,488.[7]林弘睿,万乃君,钱艺,等.小儿肺热咳喘口服液联合阿奇霉素对肺炎支原体肺炎患儿肺功能和炎性因子的影响[J].现代生物医学进展,2019,19(17):3267-3270,3217.[8]朱亦凡,杨一凡,谢雯雯,等.小儿肺热咳喘口服液联合阿奇霉素对比小儿消积止咳口服液联合阿奇霉素治疗小儿支原体肺炎的药物经济学评价[J].中国新药杂志,2019,28(15):1913-1920.[9]席晓宇,杨一凡,林国华,等.小儿肺热咳喘口服液联合阿奇霉素对比痰热清注射液联合阿奇霉素治疗小儿肺炎的系统评价[J].中国医院药学杂志,2019,39(7):727-731.[10]王芳,王森,王川.小儿肺热咳喘口服液联合美洛西林钠治疗小儿肺炎的临床研究[J].现代药物与临床,2018,33(7):1664-1667.[11]陈羽,申建国,张亮,等.柴胡桂枝汤加减联合头孢克洛干混悬剂治疗脾胃湿热型小儿肠系膜淋巴结炎临床观察[J].河北中医,2020,42(3):406-409.[12]丁波,李智敏,李雅莉,等.复方芩兰口服液联合乙酰半胱氨酸治疗小儿支气管肺炎临床疗效及对Th1/Th2、免疫球蛋白水平的影响[J].微循环学杂志,2023,33(2):74-79.[13]史小亮,何亚红,李晓刚.小儿肺咳颗粒联合布地奈德治疗支气管肺炎患儿疗效观察及对血小板参数的影响[J].血栓与止血学,2022,28(3):941-943.[14]王贝贝,高灵红,张巧灵.布地奈德联合异丙托溴铵和特布他林雾化吸入治疗小儿支气管肺炎的临床疗效及影响因素分析[J].中国妇幼保健,2022,37(17):3218-3221.[15]王玲莉,瞿色华,王德志.布地奈德、异丙托溴铵联合沙丁胺醇雾化吸入治疗小儿支气管肺炎的效果及对TGF-β1、CRP的影响[J].湖南师范大学学报(医学版),2021,18(4):230-233.[16]李佳贤,吕健,支英杰,等.痰热清注射液联合头孢呋辛钠治疗小儿支气管肺炎疗效的系统评价[J].世界中医药,2021,16(14):2138-2144,2149.[17]雷丽,樊扬,吕洁,等.布地奈德联合氨溴索治疗小儿支气管肺炎的疗效及对相关炎症指标、免疫因子的影响[J].北华大学学报(自然科学版),2020,21(3):366-370.[18]王安琪,厉兰,彭贻界.小儿肺咳颗粒联合红霉素治疗儿童支气管肺炎的疗效及对血清APC、IL-1R1水平的影响[J].国际检验医学杂志,2020,41(18):2259-2263.[19]贾荣杰.小儿肺热咳喘颗粒辅助治疗痰热壅肺型小儿支气管肺炎的疗效及对血清活化蛋白和白细胞介素1受体的影响[J].中国基层医药,2020,27(5):537-540.[20]李才学,陈云龙,王忠敏,等.小儿咳喘灵颗粒联合盐酸氨溴索口服液治疗小儿支气管肺炎对肺功能、免疫功能、FeNO、EOS、PCT及CRP水平的影响[J].中药材,2022,45(5):1262-1265.

更新日期/Last Update: 1900-01-01